Advertisement
Screener

XERIS BIOPHARMA HOLDINGS, INC. (XERS) Net Margin

XERIS BIOPHARMA HOLDINGS, INC. (XERS) Net Margin

  • 2026-06-30: Net Margin -33.77%.
  • 2026-03-31: Net Margin 2.69%.
  • 2025-12-31: Net Margin 12.91%.
  • 2025-09-30: Net Margin 0.83%.

Complete source-backed net margin history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-33.77%
2026-03-312.69%
2025-12-3112.91%
2025-09-300.83%
2025-06-30-2.70%
2025-03-31-15.34%
2024-12-31-8.51%
2024-09-30-29.00%
2024-06-30-31.22%
2024-03-31-46.71%
2023-12-31-30.16%
2023-09-30-25.23%
2023-06-30-52.20%
2023-03-31-50.71%
2022-12-31-39.01%
2022-09-30-73.44%
2022-06-30-103.47%
2022-03-31-152.74%
2021-12-31-237.02%
2021-09-30-235.16%
2021-06-30-308.95%
2021-03-31-228.68%
2020-12-31-308.32%
2020-09-30-170.14%

Annual Net Margin

DateNet Margin
2025-12-310.19%
2024-12-31-27.00%
2023-12-31-37.98%
2022-12-31-85.86%
2021-12-31-247.48%
2020-12-31-452.20%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Innoviva, Inc. (INVA)United States$1.493B4.62
Xencor Inc (XNCR)United States$1.776B-7.33
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Septerna, Inc. (SEPN)United States$1.783B-63.01